Chemoinformaics analysis of 4-Isopropyl-6-methyltetralone 
| Molecular Weight | 202.297 | nRot | 1 | 
| Heavy Atom Molecular Weight | 184.153 | nRig | 12 | 
| Exact Molecular Weight | 202.136 | nRing | 2 | 
| Solubility: LogS | -5.218 | nHRing | 0 | 
| Solubility: LogP | 3.961 | No. of Aliphatic Rings | 1 | 
| Acid Count | 0 | No. of Aromatic Rings | 1 | 
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 | 
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 | 
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 | 
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 | 
| nBridge Head | 0 | No. Saturated Carbocycles | 0 | 
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 | 
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 | 
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 | 
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 | 
| nHA | 1 | APOL | 36.1843 | 
| nHD | 0 | BPOL | 18.9257 | 
| QED | 0.678 | 
| Synth | 2.775 | 
| Natural Product Likeliness | 0.955 | 
| NR-PPAR-gamma | 0.004 | 
| Lipinski | Accepted | 
| Pfizer | Rejected | 
| GSK | Accepted | 
| Golden Triangle | Accepted | 
| Pgp-inh | 0.555 | 
| Pgp-sub | 0.002 | 
| HIA | 0.002 | 
| CACO-2 | -4.523 | 
| MDCK | 0.0000193 | 
| BBB | 0.971 | 
| PPB | 0.921597 | 
| VDSS | 0.529 | 
| FU | 0.0764399 | 
| CYP1A2-inh | 0.36 | 
| CYP1A2-sub | 0.93 | 
| CYP2c19-inh | 0.805 | 
| CYP2c19-sub | 0.878 | 
| CYP2c9-inh | 0.659 | 
| CYP2c9-sub | 0.823 | 
| CYP2d6-inh | 0.056 | 
| CYP2d6-sub | 0.673 | 
| CYP3a4-inh | 0.3 | 
| CYP3a4-sub | 0.584 | 
| CL | 6.995 | 
| T12 | 0.162 | 
| hERG | 0.04 | 
| Ames | 0.261 | 
| ROA | 0.141 | 
| SkinSen | 0.044 | 
| Carcinogencity | 0.431 | 
| EI | 0.324 | 
| Respiratory | 0.633 | 
| NR-Aromatase | 0.008 | 
| Antiviral | Yes | 
| Prediction | 0.718137 |